Eligible Registrants – AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Concurrent Session 2: Epigenetics and Targeting Transcription

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3
Rational cancer & immune cell therapy combinations a functional genomics approach
Daniel Peeper
Netherlands Cancer Institute, Amsterdam, Netherlands
from 2019 Molecular Targets and Cancer Therapeutics conference on October 27, 2019 4:15 PM-6:00 PM
Discovery and development of HIF-2a inhibitors for the treatment of clear cell renal cell carcinoma
Eli Wallace
Peloton Therapeutics, Inc., Dallas, TX, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 27, 2019 4:15 PM-6:00 PM
Targeting the opposing roles of IFN for cancer immunotherapy
Andy J. Minn
Abramson Family Cancer Research Institute, Philadelphia, PA, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 27, 2019 4:15 PM-6:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3